Cytomed Therapeutics Limited Stock Price History

If you're considering investing in CytoMed Stock, it is important to understand the factors that can impact its price. As of today, the current price of CytoMed Therapeutics stands at 2.55, as last reported on the 23rd of January, with the highest price reaching 2.55 and the lowest price hitting 2.47 during the day. CytoMed Therapeutics appears to be dangerous, given 3 months investment horizon. CytoMed Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0225, which signifies that the company had a 0.0225 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for CytoMed Therapeutics Limited, which you can use to evaluate the volatility of the firm. Please makes use of CytoMed Therapeutics' Risk Adjusted Performance of 0.0738, downside deviation of 7.83, and Mean Deviation of 6.04 to double-check if our risk estimates are consistent with your expectations. At present, CytoMed Therapeutics' Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock is expected to grow to about 21.7 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 8.1 M. . At present, CytoMed Therapeutics' Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price Sales Ratio is expected to grow to 316.54, whereas Price Earnings Ratio is forecasted to decline to (15.72). CytoMed Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0225

Best Portfolio	Best Equity
Good Returns
Average Returns
Small Returns				GDTC
Cash	Small Risk	Average Risk	High Risk	Huge Risk
Negative Returns

Estimated Market Risk

Expected Return

Risk-Adjusted Return